XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 42 filers reported holding XENON PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $1,249,000 | +16.3% | 69,800 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $1,074,000 | +24.7% | 69,800 | -10.3% | 0.00% | 0.0% |
Q3 2020 | $861,000 | -12.1% | 77,788 | -0.4% | 0.00% | 0.0% |
Q2 2020 | $979,000 | +73.3% | 78,107 | +56.7% | 0.00% | 0.0% |
Q1 2020 | $565,000 | -26.4% | 49,855 | -14.9% | 0.00% | 0.0% |
Q4 2019 | $768,000 | +36.9% | 58,555 | -5.9% | 0.00% | 0.0% |
Q3 2019 | $561,000 | +1.4% | 62,255 | +11.0% | 0.00% | 0.0% |
Q2 2019 | $553,000 | -1.1% | 56,105 | +2.0% | 0.00% | 0.0% |
Q1 2019 | $559,000 | +61.1% | 55,000 | 0.0% | 0.00% | – |
Q4 2018 | $347,000 | -52.2% | 55,000 | 0.0% | 0.00% | -100.0% |
Q3 2018 | $726,000 | +43.5% | 55,000 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $506,000 | +87.4% | 55,000 | 0.0% | 0.00% | – |
Q1 2018 | $270,000 | +74.2% | 55,000 | 0.0% | 0.00% | – |
Q4 2017 | $155,000 | -4.3% | 55,000 | 0.0% | 0.00% | – |
Q3 2017 | $162,000 | -6.4% | 55,000 | 0.0% | 0.00% | – |
Q2 2017 | $173,000 | -21.4% | 55,000 | 0.0% | 0.00% | – |
Q1 2017 | $220,000 | -48.1% | 55,000 | 0.0% | 0.00% | -100.0% |
Q4 2016 | $424,000 | – | 55,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 266,961 | $10,277,999 | 12.45% |
COMMODORE CAPITAL LP | 1,845,000 | $71,032,500 | 7.98% |
Altium Capital Management LP | 228,000 | $8,778,000 | 6.64% |
TLS Advisors LLC | 33,756 | $1,300 | 5.58% |
GREAT POINT PARTNERS LLC | 530,000 | $20,405,000 | 3.99% |
DAFNA Capital Management LLC | 280,538 | $10,800,713 | 2.95% |
Paradigm Biocapital Advisors LP | 989,327 | $38,089,090 | 2.94% |
Nan Fung Group Holdings Ltd | 114,380 | $4,403,630 | 2.81% |
Avoro Capital Advisors LLC | 4,900,000 | $188,650,000 | 2.56% |
Ghost Tree Capital, LLC | 185,000 | $7,122,500 | 2.35% |